Concepedia

Xiaokang Lu

XL

Statistics

Publications

3

Citations

234

H-Index

3

Active since

2000

Affiliations

Novartis (China)(Current)

Xiaokang Lu is an author at Novartis (China) specializing in pathology, immunology, and inflammation.

Top concepts

HealthMedicinePathologyImmunologyMetabolismPhysiologyInflammationPharmacologyAtherosclerosisVascular Biology

Publications per year

2000–2025

3

Publications

3

The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic Rabbits

Thomas Bocan, Brian R. Krause, Wendy S. Rosebury et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 113 citations · Full text

Vascular Disease, Matrix Metalloproteinase Expression, Immunology +18

Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Is Induced Upon Monocyte Differentiation and Is Expressed in Human Atheroma

Terry C. Major, Liang Liang, Xiaokang Lu et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 102 citations

Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor

Dong-Ming Shen, Kate F. Byth, Damien Bertheloot et al. · Journal of Medicinal Chemistry · 2025 · 19 citations

1–3 of 3